198 related articles for article (PubMed ID: 34826787)
21. Statewide Availability of Buprenorphine/Naloxone in Acute Care Hospitals.
Pham S; Haigh A; Barrett E
J Addict Med; 2022 Jan-Feb 01; 16(1):e48-e51. PubMed ID: 33758118
[TBL] [Abstract][Full Text] [Related]
22. Barriers and facilitators for emergency department initiation of buprenorphine: A physician survey.
Lowenstein M; Kilaru A; Perrone J; Hemmons J; Abdel-Rahman D; Meisel ZF; Delgado MK
Am J Emerg Med; 2019 Sep; 37(9):1787-1790. PubMed ID: 30803850
[No Abstract] [Full Text] [Related]
23. Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program.
Kaucher KA; Caruso EH; Sungar G; Gawenus L; Hurlbut K; Sanchez DC; Broderick K
Am J Emerg Med; 2020 Feb; 38(2):300-304. PubMed ID: 31387811
[TBL] [Abstract][Full Text] [Related]
24. Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder.
Williams AR; Samples H; Crystal S; Olfson M
Am J Psychiatry; 2020 Feb; 177(2):117-124. PubMed ID: 31786933
[TBL] [Abstract][Full Text] [Related]
25. Barriers and facilitators associated with establishment of emergency department-initiated buprenorphine for opioid use disorder in rural Maine.
Rosenberg NK; Hill AB; Johnsky L; Wiegn D; Merchant RC
J Rural Health; 2022 Jun; 38(3):612-619. PubMed ID: 34468047
[TBL] [Abstract][Full Text] [Related]
26. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.
Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE
Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535
[TBL] [Abstract][Full Text] [Related]
27. Improving Uptake of Emergency Department-initiated Buprenorphine: Barriers and Solutions.
Kelly TD; Hawk KF; Samuels EA; Strayer RJ; Hoppe JA
West J Emerg Med; 2022 Jul; 23(4):461-467. PubMed ID: 35980414
[TBL] [Abstract][Full Text] [Related]
28. Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden.
Kazerouni NJ; Irwin AN; Levander XA; Geddes J; Johnston K; Gostanian CJ; Mayfield BS; Montgomery BT; Graalum DC; Hartung DM
Drug Alcohol Depend; 2021 Jul; 224():108729. PubMed ID: 33932744
[TBL] [Abstract][Full Text] [Related]
29. Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California.
Herring AA; Kalmin M; Speener M; Goodman-Meza D; Snyder H; Campbell A; Moulin A; Shoptaw S
J Subst Abuse Treat; 2021 Apr; 123():108260. PubMed ID: 33612194
[TBL] [Abstract][Full Text] [Related]
30. Tele-buprenorphine for emergency department overdose visit follow up and treatment initiation.
Wightman RS; Jacka B; Uber J; McKenzie M; Reddy NG; Winters R; Jordison Keeler LA; Samuels EA
Am J Emerg Med; 2021 Dec; 50():409-412. PubMed ID: 34481260
[TBL] [Abstract][Full Text] [Related]
31. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
[TBL] [Abstract][Full Text] [Related]
32. Emergency Department Clinicians' Attitudes Toward Opioid Use Disorder and Emergency Department-initiated Buprenorphine Treatment: A Mixed-Methods Study.
Im DD; Chary A; Condella AL; Vongsachang H; Carlson LC; Vogel L; Martin A; Kunzler N; Weiner SG; Samuels-Kalow M
West J Emerg Med; 2020 Feb; 21(2):261-271. PubMed ID: 32191184
[TBL] [Abstract][Full Text] [Related]
33. Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department-Initiated Buprenorphine Programs.
Sue KL; Chawarski M; Curry L; McNeil R; Coupet E; Schwartz RP; Wilder C; Tsui JI; Hawk KF; D'Onofrio G; O'Connor PG; Fiellin DA; Edelman EJ
JAMA Netw Open; 2023 May; 6(5):e2312718. PubMed ID: 37163263
[TBL] [Abstract][Full Text] [Related]
34. Results From the POINT Pragmatic Randomized Trial: An Emergency Department-Based Peer Support Specialist Intervention to Increase Opioid Use Disorder Treatment Linkage and Reduce Recurrent Overdose.
Watson DP; Tillson M; Taylor L; Xu H; Ouyang F; Beaudoin FL; O'Donnell D; McGuire AB
Subst Use Addctn J; 2024 Jul; 45(3):378-389. PubMed ID: 38258819
[TBL] [Abstract][Full Text] [Related]
35. Relationship of County Opioid Epidemic Severity to Changes in Access to Substance Use Disorder Treatment, 2009-2017.
Yarbrough CR; Abraham AJ; Adams GB
Psychiatr Serv; 2020 Jan; 71(1):12-20. PubMed ID: 31575353
[TBL] [Abstract][Full Text] [Related]
36. Emergency Department-Initiated Interventions for Illicit Drug Overdose: An Integrative Review of Best Practices.
Mechling BM; Ahern N; Palumbo R; Bebawy A; Zumpe RL
J Psychosoc Nurs Ment Health Serv; 2023 Jun; 61(6):18-24. PubMed ID: 36479869
[TBL] [Abstract][Full Text] [Related]
37. Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island.
Clark SA; Davis C; Wightman RS; Wunsch C; Keeler LAJ; Reddy N; Samuels EA
J Subst Abuse Treat; 2021 May; 124():108283. PubMed ID: 33771282
[TBL] [Abstract][Full Text] [Related]
38. Rates of substance use disorder treatment seeking visits after emergency department-initiated buprenorphine.
Jennings LK; Bogan C; McCauley JJ; Moreland A; Lane S; Ward R; Hartwell KJ; Haynes L; Brady KT
Am J Emerg Med; 2020 May; 38(5):975-978. PubMed ID: 32081555
[TBL] [Abstract][Full Text] [Related]
39. Models for Implementing Emergency Department-Initiated Buprenorphine With Referral for Ongoing Medication Treatment at Emergency Department Discharge in Diverse Academic Centers.
Whiteside LK; D'Onofrio G; Fiellin DA; Edelman EJ; Richardson L; O'Connor P; Rothman RE; Cowan E; Lyons MS; Fockele CE; Saheed M; Freiermuth C; Punches BE; Guo C; Martel S; Owens PH; Coupet E; Hawk KF
Ann Emerg Med; 2022 Nov; 80(5):410-419. PubMed ID: 35752520
[TBL] [Abstract][Full Text] [Related]
40. Continuation of outpatient buprenorphine therapy after dispensing Buprenorphine-Naloxone from the emergency department.
Krenz JR; Hayes BD; Wakeman SE; Martin A; Raja AS; White BA; Koehl JL
Clin Toxicol (Phila); 2022 Apr; 60(4):429-432. PubMed ID: 34409916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
